BioSniper

FDA Approvals

FDA approval decisions mark the culmination of the drug development process. An approved drug can be commercially marketed in the United States, often transforming a biotech company's revenue trajectory.

0 upcoming events tracked. Updated hourly.

No upcoming fda approvals currently scheduled. Check back soon.

Learn more

What Is PDUFA? A Complete Guide for Biotech Investors

Understand PDUFA dates, how the FDA review process works, and why PDUFA action dates are the most important catalysts in biotech investing.

FDA Complete Response Letters (CRLs): What They Mean for Biotech Investors

Learn what a Complete Response Letter is, why the FDA issues CRLs, how companies respond, and what CRL outcomes mean for biotech stock prices and timelines.

Orphan Drug Designation: Why Rare Disease Drugs Are a Strategic Goldmine

Understand FDA Orphan Drug Designation, its financial incentives, market exclusivity benefits, and why rare disease biotech companies attract premium valuations.

Browse by event type

PDUFA DatesAdCom MeetingsPhase 3 ReadoutsPhase 2 ReadoutsEarningsAll Events
BioSniper

AI-Powered Biotech Data Intelligence Platform

Product

  • Pricing
  • FAQ

Resources

  • Event Calendar
  • PDUFA Calendar
  • AdCom Schedule
  • Blog
  • About

Data & Tools

  • Cash Runway Calculator
  • Trial Success Rates
  • FDA Review Timelines
  • PDUFA Complete Guide
  • Reading FDA AdCom Results

Legal

  • Privacy Policy
  • Terms of Service
  • Refund Policy
  • Contact Us

BioSniper is a data analytics SaaS tool for research purposes only. It does not constitute professional advice of any kind. Users should independently verify data and make their own decisions.

© 2026 Biosniper All rights reserved.Payments powered by Paddle